Atlas market file · Equity · United States
Privia Health Group, Inc.PRVA
- Last close
- 22.45
- Change
- +2.05%
- 96-bar range
- 19.53 – 28.82
- As of
- 7 Aug 2026
Privia Health Group, Inc. is a services-health services issuer listed as PRVA on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+7.62% over the window).
Source rail: Yahoo Finance chart API (PRVA). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for PRVA. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
PRVA public profile
Services-health services issuer. Privia Health Group, Inc. is connected to current market context, cited company sources and its retained research file.
Privia Health Group, Inc. trades as PRVA on NASDAQ. Privia Health Group, Inc. (PRVA) has a latest verified close of 22.45, up 2.05%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files PRVA under USA Stocks and Healthcare & Medicine Stocks for browsing.
What changed for Privia Health Group, Inc. today
Privia Health Group, Inc. (Nasdaq: PRVA) last filed a 10-Q for the quarter ended 31 March 2026, showing assets of $1.42bn against liabilities of $612m, equity of $753.1m, and a net income attributable to the parent of just $3.1m. Operating income clocked in at $7.4m, while cash and cash equivalents stood at $419.5m, but net cash used in operating activities was a less impressive $49.5m. Earnings per share, diluted, came in at $0.02 on 130.9m weighted average shares outstanding. The figures are real, the network is expanding to 25 states, and the PR machine is running hot-yet the cash-generating machine is still warming up.
What Privia actually does is operate a physician-led primary care network supported by a ‘customised, physician-friendly tech platform’ designed to streamline workflows and drive value-based care. The company’s press releases and multimedia pages lean into the idea of transforming the patient and provider experience, complete with celebratory graphics and celebratory language. The evidence shows a growing footprint in US primary care, but the financial translation is still catching up to the slide deck.
On the filings front, the most recent 10-Q is the clearest snapshot: net income of $3.1m, operating income of $7.4m, and a cash outflow from operations of $49.5m for the quarter. Shareholders’ equity is $753.1m, and the balance sheet remains solvent, but the income statement’s margin for error is thinner than a hospital corridor at visiting hours. The company’s investor materials and product pages emphasise patient empowerment and provider enablement, yet the concrete numbers remain stubbornly modest for a firm that markets itself as a platform play. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1759655/000175965526000056/prva-20260706.htm; Newsroom and Information Center, https://www.priviahealth.com/information-center)
The path to deeper insight runs through the next earnings release and the operating metrics that underpin the network’s growth. Until then, the files are consistent on structure, but the punchline is still on deferred delivery. The company’s multimedia centre and press pages are lively, but they do not file the cash-flow statement.
For context on the operating story, Privia’s ‘25th State’ press note and its ‘Technology to Power Private Practices’ video are the closest public windows into how the platform is supposed to work in practice. They are informative, not audited, and they illustrate the ambition rather than the outcome. (source: Press Releases, https://www.priviahealth.com/press-releases; Technology to Power Private Practices | Privia Health, https://www.priviahealth.com/video/technology-to-power-private-practices)
The SEC submissions JSON confirms the filing cadence and the absence of a recent 10-K or 10-Q beyond March 2026, so the next scheduled disclosure will be the best test of whether the platform is translating into platform economics. (source: SEC submissions JSON, https://data.sec.gov/submissions/CIK0001759655.json)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
PRVA technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on PRVA
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep PRVA research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
PRVA FAQ
What is Privia Health Group, Inc. (PRVA)?Privia Health Group, Inc. (PRVA) has a latest verified close of 22.45, up 2.05%, dated 7 Aug 2026. Use this page to check the price chart, company context,...
Privia Health Group, Inc. (PRVA) has a latest verified close of 22.45, up 2.05%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for PRVA?Privia Health Group, Inc. (PRVA) has a latest verified close of 22.45, up 2.05%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources,...
Privia Health Group, Inc. (PRVA) has a latest verified close of 22.45, up 2.05%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files PRVA under USA Stocks and Healthcare & Medicine Stocks for browsing.
How often is the PRVA page updated?The PRVA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The PRVA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for PRVA?The PRVA file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:PRVA. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The PRVA file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:PRVA. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on PRVA?Yes. The workstation can open PRVA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open PRVA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this PRVA page investment advice?No. The PRVA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The PRVA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
PRVA
Equity · evidence first